Skip to content
lifestyle.tvshowauditions.info
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ASCENTAGE PHARMA GROUP INTERNATIONAL
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
May 31, 2026
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
May 31, 2026
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
May 31, 2026
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
May 21, 2026
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
May 12, 2026
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
May 12, 2026
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
April 21, 2026
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
April 19, 2026
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
March 25, 2026
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
March 17, 2026
1
2
Next Page
→